These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery. Oyarzun-Ampuero FA; Rivera-Rodríguez GR; Alonso MJ; Torres D Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914 [TBL] [Abstract][Full Text] [Related]
3. Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers. Lozano MV; Torrecilla D; Torres D; Vidal A; Domínguez F; Alonso MJ Biomacromolecules; 2008 Aug; 9(8):2186-93. PubMed ID: 18637687 [TBL] [Abstract][Full Text] [Related]
5. Poly-L-asparagine nanocapsules as anticancer drug delivery vehicles. Rivera-Rodríguez GR; Alonso MJ; Torres D Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):481-7. PubMed ID: 23954509 [TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery. Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of lipid immuno-nanocapsules for directed drug delivery: selective antitumor activity against HER2 positive breast-cancer cells. Sánchez-Moreno P; Ortega-Vinuesa JL; Boulaiz H; Marchal JA; Peula-García JM Biomacromolecules; 2013 Dec; 14(12):4248-59. PubMed ID: 24134122 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. Zhang W; Gilstrap K; Wu L; K C RB; Moss MA; Wang Q; Lu X; He X ACS Nano; 2010 Nov; 4(11):6747-59. PubMed ID: 21038924 [TBL] [Abstract][Full Text] [Related]
9. The encapsulation and intracellular delivery of trehalose using a thermally responsive nanocapsule. Zhang W; Rong J; Wang Q; He X Nanotechnology; 2009 Jul; 20(27):275101. PubMed ID: 19528681 [TBL] [Abstract][Full Text] [Related]
10. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells. Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725 [TBL] [Abstract][Full Text] [Related]
11. Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors. Castro A; Berois N; Malanga A; Ortega C; Oppezzo P; Pristch O; Mombrú AW; Osinaga E; Pardo H Int J Biol Macromol; 2021 Jul; 182():806-814. PubMed ID: 33857513 [TBL] [Abstract][Full Text] [Related]
12. Engineering pectin-based hollow nanocapsules for delivery of anticancer drug. Ji F; Li J; Qin Z; Yang B; Zhang E; Dong D; Wang J; Wen Y; Tian L; Yao F Carbohydr Polym; 2017 Dec; 177():86-96. PubMed ID: 28962799 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Bae WK; Park MS; Lee JH; Hwang JE; Shim HJ; Cho SH; Kim DE; Ko HM; Cho CS; Park IK; Chung IJ Biomaterials; 2013 Jan; 34(4):1433-41. PubMed ID: 23174142 [TBL] [Abstract][Full Text] [Related]
14. Role of the templating approach in influencing the suitability of polymeric nanocapsules for drug delivery: LbL vs SC/MS. Goethals EC; Shukla R; Mistry V; Bhargava SK; Bansal V Langmuir; 2013 Oct; 29(39):12212-9. PubMed ID: 23998648 [TBL] [Abstract][Full Text] [Related]
15. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies. Zafar S; Akhter S; Ahmad I; Hafeez Z; Alam Rizvi MM; Jain GK; Ahmad FJ Colloids Surf B Biointerfaces; 2020 Feb; 186():110603. PubMed ID: 31846892 [TBL] [Abstract][Full Text] [Related]
16. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy. Oh KS; Lee H; Kim JY; Koo EJ; Lee EH; Park JH; Kim SY; Kim K; Kwon IC; Yuk SH J Control Release; 2013 Jan; 165(1):9-15. PubMed ID: 23103984 [TBL] [Abstract][Full Text] [Related]
17. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size. Abellan-Pose R; Teijeiro-Valiño C; Santander-Ortega MJ; Borrajo E; Vidal A; Garcia-Fuentes M; Csaba N; Alonso MJ Int J Pharm; 2016 Jul; 509(1-2):107-117. PubMed ID: 27210735 [TBL] [Abstract][Full Text] [Related]
18. Decoupling the effects of the size, wall thickness, and porosity of curcumin-loaded chitosan nanocapsules on their anticancer efficacy: size is the winner. Goethals EC; Elbaz A; Lopata AL; Bhargava SK; Bansal V Langmuir; 2013 Jan; 29(2):658-66. PubMed ID: 23078204 [TBL] [Abstract][Full Text] [Related]
19. Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities. Wu J; Bu X; Dou L; Fang L; Shen Q J Biomed Nanotechnol; 2015 Oct; 11(10):1847-57. PubMed ID: 26502647 [TBL] [Abstract][Full Text] [Related]
20. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Attili-Qadri S; Karra N; Nemirovski A; Schwob O; Talmon Y; Nassar T; Benita S Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17498-503. PubMed ID: 24101508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]